Tag: Radiopharmaceuticals

Kaluga is expected to complete its program for radiopharmaceuticals in two years

radiopharmaceutical drug
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.

National PET-Technology network covers nine Russian regions

PET-Technology, the national network of nuclear medicine centers established with the RUSNANO support, opened its 10th center in Samara. The investments in Samara center amounted to more than 410 million rubles.

UrFU researchers will create methods for targeted delivery of cancer drugs

The scientists at the Cyclotron Center for Nuclear Medicine of the Ural Federal University will design new methods for targeted delivery of drugs to the malignant tumor location

Russian scientists receive award for unique R&D in the area of oncology

The award of the Government of the Russian Federation was given for the development, manufacturing and implementation of Russian radioactive sources for contact radiation therapy

Telix Pharmaceuticals will transfer its technology to Japan

Telix Pharmaceuticals, a biopharmaceutical company focused on the development of targeted radiopharmaceuticals or “molecularly-targeted radiation”, announced the establishment Telix Pharmaceuticals Japan

USU will develop technology for manufacturing radiopharmaceuticals

radiopharmaceutical drug
A center for personalized nuclear medicine was opened on the basis of the Ulyanovsk State University. The new center will ensure the development of technology for manufacturing the radiopharmaceuticals.

Novartis plans to buy French radiopharmaceutical company

Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications, a radiopharmaceutical firm established by physicist Stefano Buono in 2002

Norgine launches a new radiopharmaceutical in Finland and Sweden

Norgine B.V. today announced the launch of LYMPHOSEEK® (Tc 99m tilmanocept) in Finland and Sweden

Tomsk researchers develop a radiopharmaceutical based on gamma aluminum oxide

The scientists at the Cancer Research Institute are developing a drug for diagnosis of cancer metastases in sentinel lymph nodes

Radiopharmaceutical developed in Tomsk may compete with PET

The scientists from the Cancer Research Institute are testing a radiopharmaceutical based on technetium labeled glucose

Rosatom works on import substitution of radiopharmaceuticals

The experts of the Leypunsky Institute of Physics and Power Engineering together with colleagues from Rosatom plan to implement a new projects in the area of import substitution of nuclear technology

Novartis intends to aquire radiopharmaceutical company

Novartis entered a memorandum of understanding with Advanced Accelerator Applications under which Novartis intends to commence a tender offer

Ryazan region plans to set up the manufacturing of radioactive iodine

The authorities of the Ryazan plan to establish an enterprise to manufacture the drugs for non-surgical treatment of oncological diseases

Abzena and Telix signed licence agreement

Abzena, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has signed a licence agreement with Telix Pharmaceuticals Limited

Russian radiopharmaceutical goes to preclinical trials this fall

The researchers at Tomsk Polytechnic University (TPU), together with their colleagues from the Tomsk Research Institute of Oncology and the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, have developed a radiopharmaceutical labeled with Technetium-99 isotope